Coya Therapeutics, Inc. Announces Closing of $15.25 Million Initial Public Offering
HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (“Coya” or the “Company”) (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory T cells (“Tregs”), today announced the closing […]